drugset / Trial / NCT00647907

A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections

NCT00647907

Phase 4 Completed 7 enrolled Pfizer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of Vfend for the treatment of fungal infections

Timeline

Start
2003-04
Primary completion
Completion
2004-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Voriconazole Small molecule 4 mg/kg Oral
Subject Voriconazole Small molecule 200 mg Oral
Subject Voriconazole Small molecule 300 mg Oral